Analytical Data
-
Gene name
C22orf9
- Application
-
Alternative Names
KIAA0930; C22orf9; Uncharacterized Protein KIAA0930
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6ICG6
-
Expression Region
1-404aa
-
AA Sequence
MLRAIAEERGRLSLRREVCGLGCFKDDRIVFWTWMFSTYFMEKWAPRQDDMLFYVRRKLAYSGSESGADGRKAAEPEVEVEVYRRDSKKLPGLGDPDIDWEESVCLNLILQKLDYMVTCAVCTRADGGDIHIHKKKSQQVFASPSKHPMDSKGEESKISYPNIFFMIDSFEEVFSDMTVGEGEMVCVELVASDKTNTFQGVIFQGSIRYEALKKVYDNRVSVAARMAQKMSFGFYKYSNMEFVRMKGPQGKGHAEMAVSRVSTGDTSPCGTEEDSSPASPMHERVTSFSTPPTPERNNRPAFFSPSLKRKVPRNRIAEMKKSHSANDSEEFFREDDGGADLHNATNLRSRSLSGTGRSLVGSWLKLNRADGNFLLYAHLTYVTLPLHRILTDILEVRQKPILMT
-
Molecular Weight
72.2 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C22orf9, also known as Chromosome 22 Open Reading Frame 9, is a relatively unexplored protein that has gained interest in recent years due to its potential implications in various biological processes and disease mechanisms. Located on human chromosome 22, C22orf9 is believed to play a role in cellular functions, although its specific biochemical pathways and interactions remain largely undefined. Initial studies have indicated a potential association with immune responses and cellular proliferation, suggesting that it may be involved in critical physiological processes. As researchers continue to elucidate the function of C22orf9, the focus has shifted toward the production of recombinant C22orf9 protein. This recombinant protein can be utilized to investigate its structure, interactions, and functional assays, providing crucial insights into its role in health and disease. Understanding the properties of C22orf9 through recombinant technology may lead to identifying biomarkers for diseases or therapeutic targets, particularly in conditions where its expression is altered. As such, the study of recombinantly expressed C22orf9 not only contributes to basic biological knowledge but also holds promise for translational research in the context of immunology and oncology.
